Czechia – Radioactive materials – Radiopharmaceutical 177Lu-PSMA
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
The subject of the order is the ongoing supply of the radiopharmaceutical 177Lu-PSMA, (177Lu) vipivotide tetraxetane inj. for the human therapy of patients with prostate cancer, in the form of an injection solution (for IV administration) at the reference time from the order, for a period of 4 years according to the client's current needs and related services, i.e. delivery including transport to the client's workplace.